CNS (Central Nervous System)

OMNISCAN (gadodiamide) is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues [see Clinical Studies].

Body (Intrathoracic [noncardiac], Intra-abdominal, Pelvic and Retroperitoneal Regions)

OMNISCAN (gadodiamide) is a gadolinium-based contrast agent indicated for intravenous use in MRI to facilitate the visualization of lesions with abnormal vascularity within the thoracic (noncardiac), abdominal, pelvic cavities, and the retroperitoneal space [see Clinical Studies].

CNS (Central Nervous System)

Adults: The recommended dose of OMNISCAN (gadodiamide) is 0.2 mL/kg (0.1 mmol/kg) administered as a bolus intravenous injection. Pediatric Patients (2-16 years): The recommended dose of OMNISCAN (gadodiamide) is 0.2 mL/kg (0.1 mmol/kg) administered as a bolus intravenous injection.

Body (Intrathoracic [noncardiac], Intra-abdominal, Pelvic and Retroperitoneal Regions)

Adult and Pediatric Patients (2-16 years of age): For imaging the kidney, the recommended dose of OMNISCAN (gadodiamide) is 0.1 mL/kg (0.05 mmol/kg). For imaging the intrathoracic (noncardiac), intra-abdominal, and pelvic cavities, the recommended dose of OMNISCAN (gadodiamide) is 0.2 mL/kg (0.1 mmol/kg).

Dosage Chart

Dosing Guidelines

Inspect OMNISCAN (gadodiamide) visually for particulate matter and discoloration before administration, whenever solution and container permit. Do not use the solution if it is discolored or particulate matter is present. Draw OMNISCAN (gadodiamide) into the syringe and use immediately. Discard any unused portion of OMNISCAN (gadodiamide) Injection. To ensure complete delivery of the desired volume of contrast medium, follow the injection of OMNISCAN (gadodiamide) with a 5 mL flush of 0.9% sodium chloride, as provided in the Prefill Plus needle-free system. Complete the imaging procedure within 1 hour of administration of OMNISCAN (gadodiamide) .

Dosage Forms And Strengths

Sterile aqueous solution for intravenous injection; 287 mg/mL.

Storage And Handling

OMNISCAN (gadodiamide) Injection is a sterile, clear, colorless to slightly yellow, aqueous solution containing 287 mg/mL of gadodiamide in rubber stoppered vials and polypropylene syringes. OMNSICAN is supplied in the following sizes:

5 mL fill in 10 mL vial, box of 10 (NDC 0407-0690-05)
10 mL vial, box of 10 (NDC 0407-0690-10)
15 mL fill in 20 mL vial, box of 10 (NDC 0407-0690-15)
20 mL vial, box of 10 (NDC 0407-0690-20)
50 mL vial, box of 10 (NDC 0407-0690-55)
10 mL fill in 20 mL prefilled syringe, box of 10 (NDC 0407-0690-12)
15 mL fill in 20 mL prefilled syringe, box of 10 (NDC 0407-0690-17)
20 mL prefilled syringe, box of 10 (NDC 0407-0690-22)

Prefill Plus™ needle-free system

OMNISCAN (gadodiamide) 15 mL, box of 10 (NDC 0407-0691-62)
Contains: OMNISCAN (gadodiamide) 15 mL fill in 20 mL Single Dose Prefilled Syringe and 5 mL 0.9% Sodium Chloride Injection, USP I.V. Flush Syringe

Prefill Plus™ needle-free system

OMNISCAN (gadodiamide) 20 mL, box of 10 (NDC 0407-0691-63)
Contains: OMNISCAN (gadodiamide) 20 mL fill in 20 mL Single Dose Prefilled Syringe and 5 mL 0.9% Sodium Chloride Injection, USP I.V. Flush Syringe

Protect OMNISCAN (gadodiamide) from strong daylight and direct exposure to sunlight. Do not freeze. Freezing can cause small cracks in the vials, which would compromise the sterility of the product. Do not use if the product is inadvertently frozen.

Store OMNISCAN (gadodiamide) at controlled room temperature 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP].

Distributed by GE Healthcare Inc., Princeton, NJ. Manufactured by GE Healthcare AS, Oslo, Norway. Revised: 12/2010

Last reviewed on RxList: 2/11/2011
This monograph has been modified to include the generic and brand name in many instances.